
Palforzia® Oral Immunotherapy for Peanut Allergy Now Available for U.S. Children Aged 1-3
Palforzia® Oral Immunotherapy for Peanut Allergy Now Available for U.S. Children Aged 1-3 Stallergenes Greer Launches Palforzia® for Peanut Allergy in U.S. Toddlers Aged 1-3 Stallergenes Greer, a global leader in allergy therapeutics, has announced the launch of Palforzia® [Peanut…












